Clinical Trials Directory

Trials / Completed

CompletedNCT04424355

Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.

Possibilities of Chest Magnetic Resonance Imaging (MRI) in Diagnostics of COVID-19. The Use of MRI to Assess Lung Damage in Patients With Coronavirus Infection

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Since the onset of the COVID-19 pandemic, the importance of chest computed tomography (CT) in detecting signs of viral pneumonia has become clear from the literature. However, the increased patient flow creates an additional pressure on CT centers. We believe, the use of chest magnetic resonance imaging (MRI) can help to test patients for CОVID-19 when CT scan is not available. Lung MRI may be useful in routing a patient in a difficult epidemiological situation.

Detailed description

Currently, with increased load of CT studies, alternative methods of viral pneumonia signs' visualization are required. Investigators hypothesize that chest MRI could be a test for detecting pulmonary features of COVID-19. They consider using MRI to assess COVID-19 viral pneumonia. Absence of radiation exposure to patients is a clear advantage of MRI. This is a prospective, observational cohort study assessing patients with suspected COVID-19. It's primary goal is to determine the ability of multiparametric MRI to detect lung abnormalities - ground-glass opacity (GGO), consolidation, "crazy paving" pattern, pleuritis - in comparison to CT scan. In this study each patient with suspected pneumonia will sequentially undergo both chest CT and MRI during his/her visit. Scan protocols will be identical for each patient. Each participants completed an online questionnaire.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTChest MRIPatients referred by the primary care physician with suspected pneumonia

Timeline

Start date
2020-05-19
Primary completion
2021-07-19
Completion
2021-12-20
First posted
2020-06-09
Last updated
2023-03-21

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04424355. Inclusion in this directory is not an endorsement.